Table 3 Frequency and percentage of empiric antimicrobials (before the results of the culture)
Empiric antimicrobials | Frequency N (%) |
|---|---|
Amikacin* | 45 (31.3) |
Vancomycin* | 44 (30.3) |
Meropenem* | 40 (27.8) |
Meropenem** | 2 (1.4) |
Piperacillin-Tazobactam* | 40 (27.8) |
Piperacillin- Tazobactam** | 1 (0.7) |
Colistin* | 34 (23.6) |
Colistin** | 1 (0.7) |
Tigecycline* | 27 (18.6) |
Voriconazole* | 21 (14.6) |
Fluconazole* | 18 (12.5) |
Miconazole* | 18 (12.5) |
Levofloxacin* | 16 (11.1) |
Levofloxacin** | 1 (0.7) |
Trimethoprim-Sulfamethoxazole* | 15 (10.4) |
Ceftazidime* | 10 (6.9) |
Acyclovir* | 10 (6.9) |
Metronidazole* | 8 (5.6) |
Metronidazole** | 1 (0.7) |
Ciprofloxacin* | 6 (4.5) |
Ciprofloxacin** | 1 (0.7) |
Ceftriaxone* | 4 (2.8) |
Azithromycin* | 1 (0.7) |
Azithromycin** | 1 (0.7) |
Amphotericin* | 2 (1.4) |
Caspofungin* | 1 (0.7) |
Clindamycin* | 1 (0.7) |